We propose potential pan-specific anti-leishmaniasis vaccine targets based on abundance, low similarity to human protein sequences, antigenicity, high-affinity binding epitopes for BCR and HLA, and high population coverage, as well as potential conservation by homology in thirteen Leishmania species, among the protein sequences in the immunodominant sLnAg fraction. Here, BCR is linked to leishmaniasis.